Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,General Medicine
Link
http://www.nature.com/articles/ncponc1238.pdf
Reference99 articles.
1. Ting AH et al. (2006) The cancer epigenome—components and functional correlates. Genes Dev 20: 3215–3231
2. Inche AG and La Thangue NB (2006) Chromatin control and cancer-drug discovery: realizing the promise. Drug Discov Today 11: 97–109
3. Carey N and La Thangue NB (2006) Histone deacetylase inhibitors: gathering pace. Curr Opin Pharmacol 6: 369–375
4. Marks P et al. (2001) Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 1: 194–202
5. Marks PA et al. (2004) Histone deacetylase inhibitors. Adv Cancer Res 91: 137–168
Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epigenetic modifications: Key players in cancer heterogeneity and drug resistance;Translational Oncology;2024-01
2. Progress in the research of epigenetic regulators in cancer therapy;SCIENTIA SINICA Vitae;2023-11-01
3. DUX4-r exerts a neomorphic activity that depends on GTF2I in acute lymphoblastic leukemia;Science Advances;2023-09-15
4. (‐)‐Epigallocatechin‐3‐gallate induced apoptosis by dissociation of c‐FLIP/Ku70 complex in gastric cancer cells;Journal of Cellular and Molecular Medicine;2023-08-03
5. Acetyl-CoA: An interplay between metabolism and epigenetics in cancer;Frontiers in Molecular Medicine;2022-11-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3